Hypercalcemia can occur by three mechanisms: osteolytic metastases with local release of cytokines (including osteoclast activating factors); tumor secretion of parathyroid hormone-related protein (PTHrP) and tumor production of 1,25-dihydroxyvitamin D (calcitriol) [8]. Here, PTHLH is linked to neoplasm.